−57.04 MEUR
41.54 M
About NANOBIOTIX EUR0.03
Sector
Industry
CEO
Laurent Lévy
Website
Headquarters
Paris
Employees (FY)
102
Founded
2003
ISIN
FR0011341205
FIGI
BBG00SYG78H2
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0QAV is 5.655 EUR — it has increased by 1.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NANOBIOTIX EUR0.03 stocks are traded under the ticker 0QAV.
NANOBIOTIX EUR0.03 is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
0QAV stock is 2.13% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is NANOBIOTIX EUR0.03 there?
0QAV earnings for the last quarter are −0.80 EUR per share, whereas the estimation was −0.54 EUR resulting in a −48.15% surprise. The estimated earnings for the next quarter are −0.75 EUR per share. See more details about NANOBIOTIX EUR0.03 earnings.
NANOBIOTIX EUR0.03 revenue for the last quarter amounts to 10.00 K EUR despite the estimated figure of 9.70 K EUR. In the next quarter revenue is expected to reach 1.20 M EUR.
Yes, you can track NANOBIOTIX EUR0.03 financials in yearly and quarterly reports right on TradingView.
0QAV stock has risen by 4.69% compared to the previous week, the month change is a 1.86% fall, over the last year NANOBIOTIX EUR0.03 has showed a 78.33% increase.
Today NANOBIOTIX EUR0.03 has the market capitalization of 270.89 M, it has decreased by 0.37% over the last week.
No, 0QAV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0QAV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANOBIOTIX EUR0.03 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 102.00 employees. See our rating of the largest employees — is NANOBIOTIX EUR0.03 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANOBIOTIX EUR0.03 technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANOBIOTIX EUR0.03 stock shows the sell signal. See more of NANOBIOTIX EUR0.03 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NANOBIOTIX EUR0.03 future price: according to them, 0QAV price has a max estimate of 15.00 EUR and a min estimate of 10.90 EUR. Read a more detailed NANOBIOTIX EUR0.03 forecast: see what analysts think of NANOBIOTIX EUR0.03 and suggest that you do with its stocks.